跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 396 条关于
“Evopoint”
全部
396
临床试验
81
药物
3
机构
3
资讯
309
去年
Astellas Secures $1.4 Billion License Deal for Novel CLDN18.2-Targeting ADC XNW27011
11个月前
Astellas' Vyloy Fails Phase 2 Pancreatic Cancer Trial Despite Gastric Cancer Success
7个月前
Claudin18.2 ADC Race Intensifies as AstraZeneca Prepares Pivotal Data While Chinese Competitors Advance
去年
Relacorilant Fails to Meet Primary Endpoint in GRADIENT Trial for Cushing's Syndrome
9天前
Redasemtide Clears Ulcer Endpoint in Dystrophic EB but Misses Primary Endpoint in Global Phase 2 Acute Ischemic Stroke Trial
去年
EyePoint's DURAVYU Shows Promise in Phase 2 DME Trial
去年
EyePoint's DURAVYU Shows Promise in Wet AMD and DME Trials, Anticipates Key Milestones in 2025
6年前
MRD Negativity as a Surrogate Endpoint for PFS in Multiple Myeloma
6年前
MRD Negativity as a Surrogate Endpoint for PFS in Newly Diagnosed Multiple Myeloma
去年
MACE Endpoint Faces Scrutiny in Cardiovascular Trials
第 1 页,共 31 页
上一页
下一页